Literature DB >> 16526941

TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.

Sharron A N Brown1, Heather N Hanscom, Hong Vu, Shelesa A Brew, Jeffrey A Winkles.   

Abstract

TWEAK [TNF (tumour necrosis factor)-like weak inducer of apoptosis] is a member of the TNF superfamily of cytokines. TWEAK binds with high affinity to a single TNF receptor super-family member, Fn14 (fibroblast growth factor-inducible 14). This interaction can stimulate a variety of biological responses, depending on the cell type analysed. The murine Fn14 extracellular region is only 53 amino acids in length and primarily consists of a CRD (cysteine-rich domain) containing three disulphide bonds. In the present study, we investigated whether TWEAK binding to this CRD was dependent on selected evolutionarily conserved amino acid residues by using a site-specific mutagenesis approach and several different ligand-binding assays. Our results indicate that three residues within the predicted Fn14 CRD A1 module (Asp45, Lys48 and Met50) and one residue within the predicted D2 module (Asp62) are each critical for high-affinity TWEAK binding. Mutation of the three charged polar residues Asp45, Lys48 and Asp62 had the greatest deleterious effect, suggesting that electrostatic interactions between TWEAK and Fn14 residues may be particularly important for complex formation or stability. To determine whether the four critical residues were likely to be located on the Fn14 CRD surface, we made an Fn14 homology model based on a previously derived X-ray structure for the B-cell maturation antigen receptor, which also contains only one CRD. This model revealed that each of these critical residues were in areas of the receptor that are potentially capable of interacting with TWEAK. These results indicate that the TWEAK-Fn14 interaction is highly dependent on multiple Fn14 residues located in both CRD modules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16526941      PMCID: PMC1513280          DOI: 10.1042/BJ20051362

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  The TNF and TNF receptor superfamilies: integrating mammalian biology.

Authors:  R M Locksley; N Killeen; M J Lenardo
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  The molecular architecture of the TNF superfamily.

Authors:  Jean-Luc Bodmer; Pascal Schneider; Jürg Tschopp
Journal:  Trends Biochem Sci       Date:  2002-01       Impact factor: 13.807

3.  A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis.

Authors:  S R Wiley; L Cassiano; T Lofton; T Davis-Smith; J A Winkles; V Lindner; H Liu; T O Daniel; C A Smith; W C Fanslow
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

4.  BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

Authors:  Nobuhiko Kayagaki; Minhong Yan; Dhaya Seshasayee; Hua Wang; Wyne Lee; Dorothy M French; Iqbal S Grewal; Andrea G Cochran; Nathaniel C Gordon; JianPing Yin; Melissa A Starovasnik; Vishva M Dixit
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

5.  The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration.

Authors:  R L Meighan-Mantha; D K Hsu; Y Guo; S A Brown; S L Feng; K A Peifley; G F Alberts; N G Copeland; D J Gilbert; N A Jenkins; C M Richards; J A Winkles
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

6.  TWEAK stimulation of astrocytes and the proinflammatory consequences.

Authors:  P Saas; J Boucraut; P R Walker; A L Quiquerez; M Billot; S Desplat-Jego; Y Chicheportiche; P Y Dietrich
Journal:  Glia       Date:  2000-10       Impact factor: 7.452

7.  Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.

Authors:  Sean Campbell; Linda C Burkly; Hua-Xin Gao; Joan W Berman; Lihe Su; Beth Browning; Timothy Zheng; Lena Schiffer; Jennifer S Michaelson; Chaim Putterman
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

8.  Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.

Authors:  Norihiro Harada; Masafumi Nakayama; Hiroyasu Nakano; Yoshinosuke Fukuchi; Hideo Yagita; Ko Okumura
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

9.  Dual role for TWEAK in angiogenic regulation.

Authors:  Aniela Jakubowski; Beth Browning; Matvey Lukashev; Irene Sizing; Jeffrey S Thompson; Christopher D Benjamin; Yen-Ming Hsu; Christine Ambrose; Timothy S Zheng; Linda C Burkly
Journal:  J Cell Sci       Date:  2002-01-15       Impact factor: 5.285

10.  Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies.

Authors:  Yves Chicheportiche; Rachel Chicheportiche; Irene Sizing; Jeff Thompson; Christopher B Benjamin; Christine Ambrose; Jean-Michel Dayer
Journal:  Arthritis Res       Date:  2001-11-09
View more
  28 in total

1.  Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Authors:  Isabell Lang; Simone Füllsack; Agnes Wyzgol; Andrea Fick; Johannes Trebing; José Antonio Carmona Arana; Viktoria Schäfer; Daniela Weisenberger; Harald Wajant
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

2.  Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.

Authors:  R Pattarini; R J Smeyne; J I Morgan
Journal:  Neuroscience       Date:  2007-01-29       Impact factor: 3.590

3.  The expression of Fn14 via mechanical stress-activated JNK contributes to apoptosis induction in osteoblasts.

Authors:  Hiroyuki Matsui; Naoto Fukuno; Yoshiaki Kanda; Yusuke Kantoh; Toko Chida; Yuko Nagaura; Osamu Suzuki; Hideki Nishitoh; Kohsuke Takeda; Hidenori Ichijo; Yasuhiro Sawada; Keiichi Sasaki; Takayasu Kobayashi; Shinri Tamura
Journal:  J Biol Chem       Date:  2014-01-20       Impact factor: 5.157

4.  Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.

Authors:  Harshil Dhruv; Joseph C Loftus; Pooja Narang; Joachim L Petit; Maureen Fameree; Julien Burton; Giresse Tchegho; Donald Chow; Holly Yin; Yousef Al-Abed; Michael E Berens; Nhan L Tran; Nathalie Meurice
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

5.  Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease.

Authors:  Xiaoying Chen; Vahid Farrokhi; Pratap Singh; Mireia Fernandez Ocana; Jenil Patel; Lih-Ling Lin; Hendrik Neubert; Joanne Brodfuehrer
Journal:  MAbs       Date:  2017-11-30       Impact factor: 5.857

Review 6.  A further TWEAK to multiple sclerosis pathophysiology.

Authors:  Arash Nazeri; Pouria Heydarpour; Shokufeh Sadaghiani; Mohammad Ali Sahraian; Linda C Burkly; Amit Bar-Or
Journal:  Mol Neurobiol       Date:  2013-07-20       Impact factor: 5.590

Review 7.  TWEAK and the central nervous system.

Authors:  Manuel Yepes
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 8.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

Review 9.  Surface plasmon resonance as a high throughput method to evaluate specific and non-specific binding of nanotherapeutics.

Authors:  Craig S Schneider; Adip G Bhargav; Jimena G Perez; Aniket S Wadajkar; Jeffrey A Winkles; Graeme F Woodworth; Anthony J Kim
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 10.  TWEAK and the progression of renal disease: clinical translation.

Authors:  Ana B Sanz; M Concepcion Izquierdo; Maria Dolores Sanchez-Niño; Alvaro C Ucero; Jesus Egido; Marta Ruiz-Ortega; Adrián Mario Ramos; Chaim Putterman; Alberto Ortiz
Journal:  Nephrol Dial Transplant       Date:  2014-02       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.